t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: Possible role of COX2

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Flowers, Margaret ^a   Thompson, Patricia A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CONJUGATED LINOLEIC ACID; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; I KAPPA B; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA; ERBB2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; PTGS2 PROTEIN, HUMAN; RELA PROTEIN, HUMAN; TRANS 10,CIS 12 CONJUGATED LINOLEIC ACID; TRANS-10,CIS-12-CONJUGATED LINOLEIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; ONCOGENE; PROTEIN EXPRESSION; BIOLOGICAL MODEL; BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION; GENES, ERBB-2; HUMANS; LINOLEIC ACIDS, CONJUGATED; MODELS, BIOLOGICAL; RECEPTOR, ERBB-2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65449172353     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005342     Document Type: Article

References (68)

1. Ross JS, Fletcher JA (1998) The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells 16: 413-428.
2. Yu D, Hung MC (2000) Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19: 6115-6121.
3. Nahta R, Esteva FJ (2007) Trastuzumab: triumphs and tribulations. Oncogene 26: 3637-3643.
4. Citri A, Kochupurakkal BS, Yarden Y (2004) The achilles heel of ErbB-2/ HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention. Cell Cycle 3: 51-60.
5. Moulder S, Hortobagyi GN (2008) Advances in the treatment of breast cancer. Clin Pharmacol Ther 83: 26-36.
6. Ahmed KM, Cao N, Li JJ (2006) HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer. Anticancer Res 26: 4235-4243.
7. Valabrega G, Montemurro F, Aglietta M (2007) Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. Ann Oncol 18: 977-984.
8. Nakanishi C, Toi M (2005) Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5: 297-309.
9. Biswas DK, Iglehart JD (2006) Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol 209: 645-652.
10. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
11. Sethi G, Sung B, Aggarwal BB (2008) Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233: 21-31.
12. Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, et al. (2001) The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A 98: 10386-10391.
13. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866.
14. Griffin JD (2001) Leukemia stem cells and constitutive activation of NF-kappaB. Blood 98: 2291.
15. Kim BY, Gaynor RB, Song K, Dritschilo A, Jung M (2002) Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells. Oncogene 21: 4490-4497.
16. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, et al. (2000) The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19: 5498-5506.
17. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C (2000) Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 14: 399-402.
18. Myers RB, Brown D, Oelschlager DK, Waterbor JW, Marshall ME, et al. (1996) Elevated serum levels of p105(erbB-2) in patients with advanced-stage prostatic adenocarcinoma. Int J Cancer 69: 398-402.
19. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr. (1997) Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639.
20. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD (1999) Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18: 7389-7394.
21. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, et al. (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63: 290-295.
22. Cao Y, Luo JL, Karin M (2007) IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci U S A 104: 15852-15857.
23. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, et al. (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A 101: 10137-10142.
24. Zhou Y, Yau C, Gray JW, Chew K, Dairkee SH, et al. (2007) Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer 7: 59.
25. Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, et al. (2007) NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/ or ErbB2 overexpression and MAPK hyperactivation. Br J Cancer 97: 659-669.
26. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, et al. (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403: 103-108.
27. Hardy DB, Janowski BA, Chen CC, Mendelson CR (2008) Progesterone receptor inhibits aromatase and inflammatory response pathways in breast cancer cells via ligand-dependent and ligand-independent mechanisms. Mol Endocrinol 22: 1812-1824.
28. Furstenberger G, Krieg P, Muller-Decker K, Habenicht AJ (2006) What are cyclooxygenases and lipoxygenases doing in the driver's seat of carcinogenesis? Int J Cancer 119: 2247-2254.
29. Benoit V, Relic B, Leval Xd X, Chariot A, Merville MP, et al. (2004) Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene 23: 1631-1635.
30. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C (1999) Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250: 22-34.
31. Majumder B, Wahle KW, Moir S, Schofield A, Choe SN, et al. (2002) Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Faseb J 16: 1447-1449.
32. Kemp MQ, Jeffy BD, Romagnolo DF (2003) Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr 133: 3670-3677.
33. Lim DY, Tyner AL, Park JB, Lee JY, Choi YH, et al. (2005) Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. J Cell Physiol 205: 107-113.
34. Masso-Welch PA, Zangani D, Ip C, Vaughan MM, Shoemaker S, et al. (2002) Inhibition of Angiogenesis by the Cancer Chemopreventive Agent Conjugated Linoleic Acid. Cancer Res 62: 4383-4389.
35. Hwang DM, Kundu JK, Shin JW, Lee JC, Lee HJ, et al. (2007) cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt. Carcinogenesis 28: 363-371.
36. Cheng WL, Lii CK, Chen HW, Lin TH, Liu KL (2004) Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem 52: 71-78.
37. Li G, Barnes D, Butz D, Bjorling D, Cook ME (2005) 10t,12c-conjugated linoleic acid inhibits lipopolysaccharide-induced cyclooxygenase expression in vitro and in vivo. J Lipid Res 46: 2134-2142.
38. Cho HJ, Kim WK, Jung JI, Kim EJ, Lim SS, et al. (2005) Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 11: 5142-5150.
39. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, et al. (2003) Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284: G996-1005.
40. Sroka IC, Nagle RB, Bowden GT (2007) Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Neoplasia 9: 406-417.
41. Kao J, Pollack JR (2006) RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes Chromosomes Cancer 45: 761-769.
42. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE (2001) Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287-1299.
43. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006: re13.
44. Iwakiri Y, Sampson DA, Allen KGD (2002) Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins, Leukotrienes and Essential Fatty Acids 67: 435-443.
45. Ma DW, Field CJ, Clandinin MT (2002) An enriched mixture of trans-10,cis-12-CLA inhibits linoleic acid metabolism and PGE2 synthesis in MDA-MB-231 cells. Nutr Cancer 44: 203-212.
46. Miller A, Stanton C, Devery R (2001) Modulation of arachidonic acid distribution by conjugated linoleic acid isomers and linoleic acid in MCF-7 and SW480 cancer cells. Lipids 36: 1161-1168.
47. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789.
48. Zhou BP, Hu MC, Miller SA, Yu Z, Xia W, et al. (2000) HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J Biol Chem 275: 8027-8031.
49. Weisz L, Damalas A, Liontos M, Karakaidos P, Fontemaggi G, et al. (2007) Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cells. Cancer Res 67: 2396-2401.
50. Mann M, Sheng H, Shao J, Williams CS, Pisacane PI, et al. (2001) Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth. Gastroenterology 120: 1713-1719.
51. Lee S, Yang W, Lan KH, Sellappan S, Klos K, et al. (2002) Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. Cancer Res 62: 5703-5710.
52. Menendez JA, Vellon L, Colomer R, Lupu R (2005) Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin) in breast cancer cells with Her-2/neu oncogene amplification. Ann Oncol 16: 359-371.
53. Esparis-Ogando A, Ocana A, Rodriguez-Barrueco R, Ferreira L, Borges J, et al. (2008) Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells. Ann Oncol.
54. Basu A, Mohanty S, Sun B (2001) Differential Sensitivity of Breast Cancer Cells to Tumor Necrosis Factor-[alpha]: Involvement of Protein Kinase C. Biochemical and Biophysical Research Communications 280: 883-891.
55. Ohtsu H, Ho E, Huang Y-S, Chuang L-T, Bray TM (2005) Congulated linoleic acid decreases cellular proliferation and inhibits nuclear factor-[kappa]B and activator protein 1 activation in PC3 cancerous prostate epithelial cells. Nutrition Research 25: 655-662.
56. Song HJ, Sneddon AA, Heys SD, Wahle KW (2006) Induction of apoptosis and inhibition of NF-kappaB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate 66: 839-846.
57. Kim JM, Kim JS, Kim YJ, Oh YK, Kim IY, et al. (2008) Conjugated linoleic acids produced by Lactobacillus dissociates IKK-gamma and Hsp90 complex in Helicobacter pylori-infected gastric epithelial cells. Lab Invest 88: 541-552.
58. Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, et al. (2008) Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 100: 1152-1157.
59. Degner SC, Kemp MQ, Bowden GT, Romagnolo DF (2006) Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr 136: 421-427.
60. Stein B, Baldwin AS, Jr., Ballard DW, Greene WC, Angel P, et al. (1993) Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. Embo J 12: 3879-3891.
61. Subbaramaiah K, Cole PA, Dannenberg AJ (2002) Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/ p300-dependent and -independent mechanisms. Cancer Res 62: 2522-2530.
62. Dang CT, Dannenberg AJ, Subbaramaiah K, Dickler MN, Moasser MM, et al. (2004) Phase II Study of Celecoxib and Trastuzumab in Metastatic Breast Cancer Patients Who Have Progressed after Prior Trastuzumab-Based Treatments. pp 4062-4067.
63. Howe LR, Chang S-H, Tolle KC, Dillon R, Young LJT, et al. (2005) HER2/ neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice. pp 10113-10119.
64. Howe LR, Subbaramaiah K, Patel J, Masferrer JL, Deora A, et al. (2002) Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res 62: 5405-5407.
65. Kelley NS, Hubbard NE, Erickson KL (2007) Conjugated linoleic acid isomers and cancer. J Nutr 137: 2599-2607.
66. Wahle KW, Heys SD, Rotondo D (2004) Conjugated linoleic acids: are they beneficial or detrimental to health? Prog Lipid Res 43: 553-587.
67. Meng X, Shoemaker SF, McGee SO, Ip MM (2008) t10,c12-Conjugated linoleic acid stimulates mammary tumor progression in Her2/ErbB2 mice through activation of both proliferative and survival pathways. pp 1013-1021.
68. Ip MM, McGee SO, Masso-Welch PA, Ip C, Meng X, et al. (2007) The t10,c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium. Carcinogenesis 28: 1269-1276.